Kellerhals Carrard advised Grensol throughout its CHF 1.8 million seed equity round. The proceeds will support the construction and scale-up the compay’s first operational site in Biberist, in the Canton of Solothurn, Switzerland. Buildify Earth, Kickfund, Venture Kick, W. A. de Vigier Foundation led the round, alongside several committed angel investors. Headquarterd in Zurich, Grensol […]
Walder Wyss advised askEarth, a Zurich-based deep-tech startup specialised in geospatial AI, in connection with the closing of its seed financing round. A spin-off from UZH, ETH and EPFL, the Swiss company raised an amount
Wenger Vieli advised Swiss AI company Modulos on all Swiss legal and tax matters concerning its CHF 8.7 million pre-Series A financing round. The context The proceeds from the financing round will be directed toward scaling-up
Walder Wyss advised the investors in Mosanna Therapeutics’ Series A financing round EQT Life Sciences and Pivotal bioVenture Partners led the round in question, along with Forbion, Broadview Ventures and Norwest as co-lead investors. Returning
Kellerhals Carrard advised Positrigo throughout its latest financing round. Raising an amount of CHF 7 million, the round in question was led by HealthCap, with participation from Navivo Capital as well as several family offices
Walder Wyss and Vischer are amongst the firms involved in Granite Bio’s Series A and Series B financing round. In particular Vischer advised Forbion and Sanofi Ventures on all legal issues related to their
Kellerhals Carrard advised Vaud-based start-up NovaMea and its founder Xile Hu in connection with a 9M USD series A financing round. The context Several international VCs led the capital round in question, with all proceeds
Wenger Vieli advised Swiss cleantech startup DePoly in connection with its seed financing round extension, reaching a total fundraise amount of USD 23m. The proceeds from the operation will support the inauguration of DePoly’s 500
Kellerhals Carrard advised Basel-based CGC Genomics Consults on all legal aspects of their pre-seed financing round. Pursuant to the transaction, the Swiss startup secured approximately EUR 1.7 million. The context Several impact and health-tech investors led
Kellerhals Carrard advised Bloom Biorenewables in connection with the closing of its CHF 13M Series A financing round. The investors Anaïs Ventures and Valquest Partners led the capital round in question, with further participation
